Echo Therapeutics Initiates Clinical Study Of Its Symphony(TM) Transdermal Continuous Glucose Monitoring System In Patients With Diabetes
Jul 4th 2008Drug InformationClinical Trials
Echo Therapeutics, Inc. (OTC Bulletin Board: ECTE) announced that it has initiated a clinical study of its Symphony(TM) Transdermal Continuous Glucose Monitoring System (tCGM System) in patients with Type 1 and Type 2 diabetes. The Company expects to complete and announce the results of the study in the third quarter of 2008.
More: continued here
No Comments »
Leave a Reply
You must be logged in to post a comment.
